News

Meet the newest cohort of students in the Department of Pharmacology and Cancer Biology’s PhD programs. Each student brings a unique background and a passion for research.

A New York Times article* titled "9 Federally Funded Scientific Breakthrough

Alicia Darnell, PhD, Assistant Professor of Pharmacology and Cancer Biology, was recently awarded a V Scholar grant from the

Kris Wood, PhD, Professor of Pharmacology and Cancer Biology, has been awarded a 

The Department of Pharmacology and Cancer Biology is proud to announce that  Kris Wood, PhD, has been pr

Andrew West, PhD, is one of more than 60 researchers at Duke investigating ways to prevent bad effects from plastics that break into microparticles.

The Department of Pharmacology and Cancer Biology is excited to introduce the Class of 2025.

Awards were presented at the School of Medicine Awards Ceremony on May 19th.

Congratulations to seven students in the pharmacology and molecular cancer biology PhD programs who graduated on Sunday, May 11, 2025. They were among 442 students from the Duke University School of Medicine who graduated, marking the successful culmination of their hard work and dedication.

Synovial sarcoma is a rare, aggressive soft tissue cancer with few effective treatment options, which means patients often have a poor prognosis.